Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markus Luster

Showing results (41-50 of 181) with videos related to

Pageof 19
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|June 14, 2015
Determinants of successful ablation and complete remission after total thyroidectomy and ¹³¹I therapy of paediatric differentiated thyroid cancerFrederik A Verburg, Uwe Mäder, Markus Luster, et al.
Nuklearmedizin. Nuclear Medicine|March 30, 2023
[Hand in hand - the future of SPECT and PET imaging]Friederike Eilsberger, Constantin Lapa, Benjamin Kläsner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2008
Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinomaFrederik A Verburg, Markus Dietlein, Michael Lassmann, et al.
Endocrine-Related Cancer|July 25, 2009
Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinomaHeribert Hänscheid, Michael Lassmann, Markus Luster, et al.
Nuklearmedizin. Nuclear Medicine|January 27, 2017
Prevalence of thyroid disorders in elderly people in Germany. A screening study in a country with endemic goitreFrederik A Verburg, Inge Grelle, Kathrin Tatschner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 23, 2010
ALARA in rhTSH-stimulated post-surgical thyroid remnant ablation: what is the lowest reasonably achievable activity?Daniele Barbaro, Frederik A Verburg, Markus Luster, et al.
European Journal of Clinical Investigation|May 6, 2015
Prevalence of normal TSH value among patients with autonomously functioning thyroid noduleGiorgio Treglia, Pierpaolo Trimboli, Frederik A Verburg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2018
Power of Absolute Values to Avoid Data Misinterpretations: The Case of Radioiodine-Induced Leukemia and MyelodysplasiaArnoldo Piccardo, Matteo Puntoni, Frederik A Verburg, et al.
Thyroid : Official Journal of the American Thyroid Association|April 19, 2018
Low or Undetectable Basal Thyroglobulin Levels Obviate the Need for Neck Ultrasound in Differentiated Thyroid Cancer Patients After Total Thyroidectomy and <sup>131</sup>I AblationFrederik A Verburg, Uwe Mäder, Luca Giovanella, et al.
Nature Reviews. Endocrinology|August 10, 2011
Radioiodine for remnant ablation and therapy of metastatic diseaseChristoph Reiners, Heribert Hänscheid, Markus Luster, et al.
Pageof 19

Showing results (41-50 of 181) with videos related to

Sort By:
Pageof 19
European Journal of Nuclear Medicine and Molecular Imaging|June 14, 2015
Determinants of successful ablation and complete remission after total thyroidectomy and ¹³¹I therapy of paediatric differentiated thyroid cancerFrederik A Verburg, Uwe Mäder, Markus Luster, et al.
Nuklearmedizin. Nuclear Medicine|March 30, 2023
[Hand in hand - the future of SPECT and PET imaging]Friederike Eilsberger, Constantin Lapa, Benjamin Kläsner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|December 4, 2008
Why radioiodine remnant ablation is right for most patients with differentiated thyroid carcinomaFrederik A Verburg, Markus Dietlein, Michael Lassmann, et al.
Endocrine-Related Cancer|July 25, 2009
Blood dosimetry from a single measurement of the whole body radioiodine retention in patients with differentiated thyroid carcinomaHeribert Hänscheid, Michael Lassmann, Markus Luster, et al.
Nuklearmedizin. Nuclear Medicine|January 27, 2017
Prevalence of thyroid disorders in elderly people in Germany. A screening study in a country with endemic goitreFrederik A Verburg, Inge Grelle, Kathrin Tatschner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 23, 2010
ALARA in rhTSH-stimulated post-surgical thyroid remnant ablation: what is the lowest reasonably achievable activity?Daniele Barbaro, Frederik A Verburg, Markus Luster, et al.
European Journal of Clinical Investigation|May 6, 2015
Prevalence of normal TSH value among patients with autonomously functioning thyroid noduleGiorgio Treglia, Pierpaolo Trimboli, Frederik A Verburg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2018
Power of Absolute Values to Avoid Data Misinterpretations: The Case of Radioiodine-Induced Leukemia and MyelodysplasiaArnoldo Piccardo, Matteo Puntoni, Frederik A Verburg, et al.
Thyroid : Official Journal of the American Thyroid Association|April 19, 2018
Low or Undetectable Basal Thyroglobulin Levels Obviate the Need for Neck Ultrasound in Differentiated Thyroid Cancer Patients After Total Thyroidectomy and <sup>131</sup>I AblationFrederik A Verburg, Uwe Mäder, Luca Giovanella, et al.
Nature Reviews. Endocrinology|August 10, 2011
Radioiodine for remnant ablation and therapy of metastatic diseaseChristoph Reiners, Heribert Hänscheid, Markus Luster, et al.
Pageof 19